Strides Pharma Science Ltd Nine Monthly Results

Gross Sales

3,374.94

2,846.63

2,702.02

2,204.23

2,407.38

Excise Duty

0

0

0

0

0

Net Sales

3,374.94

2,846.63

2,702.02

2,204.23

2,407.38

Other Operating Income

0

0

0

0

0

Other Income

3,326.93

108.56

81.78

45.93

97.44

Total Income

6,701.87

2,955.19

2,783.79

2,250.16

2,504.81

Total Expenditure

2,791.29

2,668.53

2,681.77

2,500.56

2,007.78

PBIDT

3,910.58

286.66

102.03

-250.39

497.03

Interest

198.53

209.12

180.63

127.26

108.46

PBDT

3,712.05

77.54

-78.6

-377.65

388.58

Depreciation

143.4

165.71

182.32

172.34

154.43

Minority Interest Before NP

0

0

0

0

0

Tax

42.34

23

-16.03

4.08

21.33

Deferred Tax

14.42

-6.41

-46.36

-50.86

-1.17

Reported Profit After Tax

3,511.89

-104.76

-198.54

-503.21

213.99

Minority Interest After NP

0.63

-15.97

-5.44

-13.78

-8.37

Net Profit after Minority Interest

3,511.26

-88.79

-193.09

-489.43

222.36

Extra-ordinary Items

3,266.45

-102.66

8.88

-165.64

39.98

Adjusted Profit After Extra-ordinary item

244.81

13.87

-201.97

-323.79

182.38

EPS (Unit Curr.)

381.61

-9.79

-21.45

-54.54

24.82

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

92.16

91.89

90.29

89.78

89.63

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

115.87

10.07

3.77

-11.35

20.64

PBDTM(%)

109.98

2.72

-2.9

-17.13

16.14

PATM(%)

104.05

-3.68

-7.34

-22.82

8.88